DNA X, Inc.
SONM· Nasdaq
SONMDNA X, Inc.
Filed Apr 15, 2026 · 10-K · 105 days after period end · 0001493152-26-016659
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $15.26M | $13.43M | $24.12M |
| Net Income | -$8.89M | -$21.61M | -$1.35M | -$1.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Apr 15, 2026 · 105 d after period end
